Axq Capital, LP Day One Biopharmaceuticals, Inc. Transaction History

Axq Capital, LP

$331 Billion
Q3 2024

A detailed history of Axq Capital, LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 10,125 shares of DAWN stock, worth $137,902. This represents 0.04% of its overall portfolio holdings.

Number of Shares

10,125

Holding current value

$137,902

% of portfolio

0.04%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$12.72 - $16.03 $128,790 - $162,303	10,125 New	10,125 $141 Million
Q1 2023 May 10, 2023	BUY	$12.75 - $23.41 $294,142 - $540,068	23,070 New	23,070 $308 Million

Others Institutions Holding DAWN

# of Institutions

178

Shares Held

84M

Call Options Held

144K

Put Options Held

218K

Ra Capital Management, L.P. Boston, MA

7.87M
Shares

$107 Million
1.53% of portfolio
Atlas Venture Life Science Advisors, LLC

6.43M
Shares

$87.6 Million
11.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.89M
Shares

$80.2 Million
0.0% of portfolio
Braidwell LP Stamford, CT

4.87M
Shares

$66.4 Million
1.92% of portfolio
Black Rock Inc. New York, NY

4.53M
Shares

$61.7 Million
0.0% of portfolio

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $1B
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.

Account